Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Trulieve Cannabis Corp.

Mexco Energy (AMEX:MXC) shares closed up 12.88% at $11.74 with an estimated market cap of $24.6M. Cansortium (OTC:CNTMF) shares closed up 8.45% at $0.77 with an estimated market cap of $170.0M.

Aurora & Trulieve Among Top Cannabis Movers For Oct 1, 2021 - Full Canna Movers Index

High Tide

Innovative Industrial Properties

WM Technology

Tilray Brands

Village Farms International

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

6 Hot Cannabis Stocks Flying High During Final Week of Q3

Canopy Growth

Cronos Group

Economist Beau Whitney is forecasting a return to normal growth for U.S. cannabis. Cannabis Cultivators, Processors & Retailers Will Face First-Ever Demand Slowdown in Q4 Massive growth in demand for cannabis during 2020-2021 is not sustainable in the coming years.

U.S. Cannabis Operators Facing Downward Pressure On Demand In Q4

Canadian cannabis giant Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) confirmed Wednesday it has rolled out Bidiol, the first medical cannabis oil in Uruguay that is wholly produced domestically. The CBD oil is available in 3% and 10% concentrations and comes in 10ml and 30ml bottles, available in pharmacies across the country "The launch of Bidiol has been two years in the making and is an integral part of our renewed strategy in Uruguay," Miguel Martin, CEO of Aurora Cannabis stated.

Aurora Cannabis Changes Strategy In Uruguay - Rolls Out Its First Medical Cannabis Oil

NASDAQ | TSX: ACB  Bidiol is the only full-spectrum cannabis oil that is fully produced domestically EDMONTON, AB, Sept. 29, 2021 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has launched Bidiol, the first medical cannabis oil in Uruguay that is wholly produced domestically.

Aurora Cannabis Launches its First Medical CBD Product in Uruguay

Analysts warn that investors may be overlooking negatives in Aurora's Monday report.

Why Aurora Cannabis Stock Wilted Today

SNDL Inc.

There are several reasons. But there are also several better cannabis stocks to own.

Why Are Sundial Growers and Aurora Cannabis Still the Most Popular Pot Stocks on Robinhood?

Aurora Cannabis Inc (NASDAQ:ACB) shares are trading higher Tuesday, although the company reported earnings with missed estimates. The company had sales of C$54.8 million, missing the analyst estimate of C$56.4 million.

It Looks Like Aurora Cannabis' Stock Is Reaching Crunch Time

Aurora Cannabis (NASDAQ:ACB) (TSX:ACB) reported a 45% year-over-year plunge in consumer cannabis net revenue, while its total net revenue in the fourth quarter of fiscal 2021 amounted to CA$54.83 million ($43.4 million), down from CA$68.43 million in the same period. On the other hand, medical cannabis net revenue grew by 9% from the prior-year period due to continued growth in the international medical business.

Is Aurora Cannabis' 'Business Transformation Plan' Yielding Results?

Aurora Cannabis Inc's top boss Miguel Martin expects the company to be profitable on a core basis in the first half of 2023, helped by C$60 million to C$80 million in cost savings.

Aurora Cannabis targets more cost cuts on path to profitability

Gogo

Forget a plunging market. Investors like these stocks.

These 2 Nasdaq Standouts Found a Way to Soar Tuesday

Aurora Cannabis had some good news to report last night.

Why Aurora Cannabis Stock Popped Today -- But All the Other Marijuana Stocks Dropped

Aurora Cannabis predicts a green year ahead, but analysts are still bearish on ACB stock. See what they are saying about this company.

Aurora Cannabis Price Predictions: Where Is ACB Stock Going After Earnings?

The shares of Aurora Cannabis Inc  (NASDAQ:ACB) are up 3.4% to trade at $6.60 at last check, despite the cannabis company  reporting worse-than-expected fiscal fourth-quarter earnings and revenue.

Aurora Cannabis Stock Brushes Off Revenue Miss, Bear Note

Canadian cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) posted its earnings for the fourth quarter and full fiscal year ended June 30, 2021, reporting on Monday a total quarterly net revenue of CA$54.83 million ($43.4 million) compared to CA$68.43 million in the same period of 2020. Q4 Financial Summary Adjusted EBITDA for the period was a loss of CA$19.26 million, which compares to a loss of CA$33.35 million in the corresponding period of the prior year;

Aurora Cannabis Posts 45% Lower Quarterly Revenue, Citing Pandemic Outbreak

MKM Partners analyst Bill Kirk on Tuesday upgraded shares of Aurora Cannabis ACB, +7.31% to neutral from sell and increased his fair value price for the stock from C$6 to C$7 after the Canadian cannabis company reported a narrower than expected EBITDA loss of C$13.9 million, compared to the consensus estimate for a loss of C$16.9 million. Kirk said Aurora continues to face a struggling recreational-use business, and despite a consistent medical business, sees volatility in the international market.

Aurora Cannabis upgraded to neutral at MKM Partners

AMC Entertainment

These widely held stocks are getting no love from analysts.

3 Ultra-Popular Stocks With No Buy Ratings on Wall Street

Fiscal fourth-quarter sales at Aurora Cannabis miss analysts' estimates but the Canadian cannabis company says cost savings should 'clear a path' for adjusted Ebitda profitability.

Aurora Cannabis Sees a Path to Profitability. The Stock Edges Lower.

Aurora Cannabis Inc. (ACB) CEO Miguel Martin on Q4 2021 Results - Earnings Call Transcript

Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 0.00% and -2.78%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc. (ACB) Reports Q4 Loss, Lags Revenue Estimates

The U.S. listed shares of Aurora Cannabis Inc (NYSE: ACB) are down more than 2.0% in after-hours trading as the company said its revenue tanked 45% in the fiscal fourth quarter on a year-over-year basis. Financial performance Aurora remained in $106 million of net loss in its recent quarter versus the year-ago figure of $1.8 […] The post Aurora Cannabis shares are trading lower after-hours: here's why appeared first on Invezz.

Aurora Cannabis shares are trading lower after-hours: here's why

Ford Motor Company

NIKE

Lordstown Motors

Aurora Cannabis, Ford, Lordstown Motors and Nike were our top stock trades for Tuesday. Now, let's get a look at the charts.

4 Top Stock Trades for Tuesday: ACB, F, RIDE, NKE

Aurora Cannabis Inc.'s sales continued to decline while losses mounted in the final three months of the Canadian company's fiscal year, sending shares lower Monday afternoon.

Aurora Cannabis sales shrink more than expected, stock falls in late trading

Aurora Cannabis Inc, reported a smaller fourth-quarter core loss on Monday, as the pot producer benefited from aggressive cost-cut measures and higher demand for cannabis and related products.

Aurora Cannabis posts smaller core loss on higher pot demand, cost cuts

NASDAQ | TSX: ACB #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68% Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million, Providing Clear Pathway to Adjusted EBITDA Profitability Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021; Working Capital Improves by $404.3 Million Compared to Prior Year Adjusted EBITDA Loss, Excluding Restructuring Costs, Narrows to $13.9 Million, a $17.6 Million Improvement Compared  to Prior Year Total Cannabis Net Revenue, Net of Provisions, of $54.8 Million Compared to $55.2 Million in the Prior Quarter, and $67.5 Million in the Year-Ago Period EDMONTON, AB, Sept. 27, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the fourth quarter and full year fiscal 2021 ended June 30, 2021.

News for Aurora Cannabis Stock (ACB)